| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | L8S50ZY490 |
| InChI Key | CBQGYUDMJHNJBX-OALUTQOASA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C19H23NO3 |
| Molecular Weight | 313.4 |
| AlogP | 3.19 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 39.72 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 23.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Norepinephrine transporter inhibitor | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2D
Cytochrome P450 2D6
|
- | 3162 | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC06 neurotransmitter transporter family
|
- | 2-3 | - | 0-1 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Fibromyalgia | 3 | D005356 | ClinicalTrials |
| Pain | 2 | D010146 | ClinicalTrials |
| Diabetic Neuropathies | 2 | D003929 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 98819-76-2 |
| ChEBI | 125535 |
| ChEMBL | CHEMBL180101 |
| DrugBank | DB12395 |
| FDA SRS | L8S50ZY490 |
| Human Metabolome Database | HMDB0014379 |
| Guide to Pharmacology | 4808 |
| PharmGKB | PA144614921 |
| PubChem | 65856 |
| SureChEMBL | SCHEMBL34534 |
| ZINC | ZINC000000006923 |